FOG-001 in Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT05919264 · RECRUITING
Trial details
- NCT number
- NCT05919264
- Sponsor
- Parabilis Medicines, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-23
- Primary completion
- 2027-04-01
- Enrollment
- 619
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.